through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
If you are among the millions of people living with gout or asymptomatic hyperuricemia (persistently high uric acid), you have likely experienced the frustration of unpredictable, excruciating pain. Gout is often called the "disease ...
What Is Bronchiectasis? Bronchiectasis (pronounced bron-kee-ek-tuh-sis) is a chronic, long-term lung condition. In healthy lungs, the airways (bronchial tubes) are flexible and lined with a thin layer of mucus that traps dust, germs, and ...
Why Is Diagnosing Asthma in Children So Difficult? Asthma is the most common chronic lung disease in children. Yet despite how common it is, diagnosing asthma in children remains surprisingly tricky—and misdiagnosis happens frequent...
Please complete the form to contact our team